References
- Kuo G, Choo Q, Alter H, Gitnick G, Redeker A, Purcell R, Miyamura T, Dienstag J, Alter M, Stevens C, Tegtmeier G, Bonino F, Colombo M, Lee W, Kuo C, Berger K, Shuster J, Overby L, Bradley D, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A. non-B hepatitis. Science 1989; 244: 362–364
- Alter H, Purcell R, Shin J, Melpolder J, Houghton M, Choo Q, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–1500
- Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362
- Weiner A, Kuo G, Bradley D, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo Q, Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 1–3
- Esteban J, Esteban R, Viladomiu L, López-Talavera J, Gonzáles A, Hernández A, Roget M, Vargas V, Genescá J, Buti M, Guardia J, Houghton M, Choo Q, Kuo G, Hepatitis C. virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989; 2: 926
- Schvarcz R, Weiland O, Wejstål R, Norkrans G, Frydén A, Foberg U. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: No correlation of outcome to presence of hepatitis C virus antibodies. Scand J Infect Dis 1989; 21: 617–625